Showing results (381-390 of 393) with videos related to
Sort By:
Pageof 40
Ebiomedicine|November 7, 2025
Genetic diagnostic yield by MRI pattern in children with cerebral palsy: a population-based studyJesia G Berry, Ajay Taranath, Robert Goetti, et al.Journal of Medicinal Chemistry|May 16, 2013
Discovery of a potent boronic acid derived inhibitor of the HCV RNA-dependent RNA polymeraseAndrew Maynard, Renae M Crosby, Byron Ellis, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 28, 2015
The Emergence of Zoonotic Onchocerca lupi Infection in the United States--A Case-SeriesPaul T Cantey, Jessica Weeks, Morven Edwards, et al.The British Journal of Dermatology|May 4, 2019
Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) studyK Molloy, C Jonak, F J S H Woei-A-Jin, et al.Journal of Fish Biology|March 15, 2018
Fishes in a changing world: learning from the past to promote sustainability of fish populationsT A C Gordon, H R Harding, F K Clever, et al.Nature|April 11, 2009
An inhibitor of NEDD8-activating enzyme as a new approach to treat cancerTeresa A Soucy, Peter G Smith, Michael A Milhollen, et al.Journal of Medicinal Chemistry|November 11, 2011
Discovery of a potent and orally bioavailable benzolactam-derived inhibitor of Polo-like kinase 1 (MLN0905)Matthew O Duffey, Tricia J Vos, Ruth Adams, et al.The British Journal of Dermatology|June 24, 2020
Should we be imaging lymph nodes at initial diagnosis of early-stage mycosis fungoides? Results from the PROspective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) international studyE Hodak, S Sherman, E Papadavid, et al.Plos One|February 15, 2017
Climatic and geographic predictors of life history variation in Eastern Massasauga (Sistrurus catenatus): A range-wide synthesisEric T Hileman, Richard B King, John M Adamski, et al.Blood|July 15, 2025
A New Prognostic Index (CLIPI) for Advanced Cutaneous Lymphoma Enables Precise Patient Risk StratificationJulia J Scarisbrick, Pietro Quaglino, Sean J Whittaker, et al.Pageof 40